4DMT Reports Full Year 2023 Financial Results and Operational Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Equities research analysts at Leerink Partnrs raised their Q4 2023 earnings per share (EPS) estimates for 4D Molecular Therapeutics in a research note issued to investors on Wednesday, February 7th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings of ($0.39) per […]
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Monday, 4D Molecular Therapeutics FDMT released interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet age-related macular…